Abbasowa, L., Kessing, L. V., & Vinberg, M. (2013). Psychostimulants in moderate to severe affective disorder: A systematic review of randomized controlled trials. Nordic Journal of Psychiatry, 67(6): 369–382.Google Scholar

Bergfeld, I. O., Mantione, M., Hoogendoorn, M. L., & Denys, D. (2013). Cognitive functioning in psychiatric disorders following deep brain stimulation. Brain Stimulation, 6(4): 532–537.Google Scholar

Borkowska, A., Drozdz, W., Ziolkowska-Kochan, M., & Rybakowski, J. (2007). Enhancing effect of mirtazapine on cognitive functions associated with prefrontal cortex in patients with recurrent depression. Neuropsychopharmacologia Hungarica, 9(3): 131–136.Google Scholar

Bowie, C. R., Gupta, M., Holshausen, K., Jokic, R., Best, M., & Milev, R. (2013). Cognitive remediation for treatment-resistant depression: Effects on cognition and functioning and the role of online homework. Journal of Nervous and Mental Disease, 201(8): 680–685.Google Scholar

Bruder, G. E., Alvarenga, J. E., Alschuler, D., Abraham, K., Keilp, J. G., Hellerstein, D. J., … McGrath, P. J. (2014). Neurocognitive predictors of antidepressant clinical response. Journal of Affective Disorders, 166: 108–114.Google Scholar

Chapman, C. D., Frey, W. H. II, Craft, S., Danielyan, L., Hallschmid, M., Schioth, H. B., & Benedict, C. (2013). Intranasal treatment of central nervous system dysfunction in humans. Pharmaceutical Research, 30(10): 2475–2484.Google Scholar

Constant, E. L., Adam, S., Gillain, B., Seron, X., Bruyer, R., & Seghers, A. (2005). Effects of sertraline on depressive symptoms and attentional and executive functions in major depression. Depression and Anxiety, 21(2): 78–89.Google Scholar

Cooney, G. M., Dwan, K., Greig, C. A., Lawlor, D. A., Rimer, J., Waugh, F. R., … Mead, G. E. (2013). Exercise for depression. The Cochrane Database of Systematic Reviews, 9: CD004366.Google Scholar

Demirtas-Tatlidede, A., Vahabzadeh-Hagh, A. M., & Pascual-Leone, A. (2013). Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders? Neuropharmacology, 64: 566–578.Google Scholar

Elgamal, S., McKinnon, M. C., Ramakrishnan, K., Joffe, R. T., & MacQueen, G. (2007). Successful computer-assisted cognitive remediation therapy in patients with unipolar depression: A proof of principle study. Psychological Medicine, 37(9): 1229–1238.Google Scholar

Ferguson, J. M., Wesnes, K. A., & Schwartz, G. E. (2003). Reboxetine versus paroxetine versus placebo: Effects on cognitive functioning in depressed patients. International Clinical Psychopharmacology, 18(1): 9–14.Google Scholar

Goss, A. J., Kaser, M., Costafreda, S. G., Sahakian, B. J., & Fu, C. H. (2013). Modafinil augmentation therapy in unipolar and bipolar depression: A systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Psychiatry, 74(11): 1101–1107.Google Scholar

Herrera-Guzman, I., Gudayol-Ferre, E., Herrera-Abarca, J. E., Herrera-Guzman, D., Montelongo-Pedraza, P., Padros Blazquez, F., … Guardia-Olmos, J. (2010a). Major depressive disorder in recovery and neuropsychological functioning: Effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with major depressive disorder in recovery. Journal of Affective Disorders, 123(1–3): 341–350.Google Scholar

Herrera-Guzman, I., Herrera-Abarca, J. E., Gudayol-Ferre, E., Herrera-Guzman, D., Gomez-Carbajal, L., Pena-Olvira, M., … Joan, G. O. (2010b). Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder. Psychiatry Research, 177(3): 323–329.Google Scholar

Hollon, S. D., DeRubeis, R. J., Fawcett, J., Amsterdam, J. D., Shelton, R. C., Zajecka, J., … Gallop, R. (2014). Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: A randomized clinical trial. JAMA Psychiatry, 71(10): 1157–1164.Google Scholar

Katona, C., Hansen, T., & Olsen, C. K. (2012). A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. International Clinical Psychopharmacology, 27(4): 215–223.Google Scholar

Legrand, F. D. (2014). Effects of exercise on physical self-concept, global self-esteem, and depression in women of low socioeconomic status with elevated depressive symptoms. Journal of Sport & Exercise Psychology, 36(4): 357–365.Google Scholar

Madhoo, M., Keefe, R. S., Roth, R. M., Sambunaris, A., Wu, J., Trivedi, M. H., … Lasser, R. (2014). Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder. Neuropsychopharmacology, 39(6): 1388–1398.Google Scholar

Mahableshwarkar, A., Zajecka, J., Jacobson, W., Chen, Y., & Keefe, R. S. (2014). Efficacy of vortioxetine on cognitive function in adult patients with major depressive disorder: Results of a randomized, double-blind, active-referenced, placebo-controlled trial. Poster presented at the 29th CINP World Congress of Neuropsychopharmacology, June 22–26, Vancouver, Canada.Google Scholar

Mammen, G. & Faulkner, G. (2013). Physical activity and the prevention of depression: A systematic review of prospective studies. American Journal of Preventive Medicine, 45(5): 649–657.Google Scholar

McIntyre, R. S., Cha, D. S., Soczynska, J. K., Woldeyohannes, H. O., Gallaugher, L. A., Kudlow, P., … Baskaran, A. (2013). Cognitive deficits and functional outcomes in major depressive disorder: Determinants, substrates, and treatment interventions. Depression and Anxiety, 30(6): 515–527.Google Scholar

McIntyre, R. S., Kennedy, S. H., Soczynska, J. K., Nguyen, H. T., Bilkey, T. S., Woldeyohannes, H. O., … Muzina, D. J. (2010). Attention-deficit/hyperactivity disorder in adults with bipolar disorder or major depressive disorder: Results from the international mood disorders collaborative project. Primary Care Companion to the Journal of Clinical Psychiatry, 12(3).Google Scholar

McIntyre, R. S., Lophaven, S., & Olsen, C. K. (2014). A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. International Journal of Neuropsychopharmacology, 17(10): 1557–1567.Google Scholar

McIntyre, R. S., Soczynska, J. K., Woldeyohannes, H. O., Miranda, A., Vaccarino, A., MacQueen, G., … Kennedy, S. H. (2012). A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder. Bipolar Disorders, 14(7): 697–706.CrossRefGoogle ScholarPubMed

Naismith, S. L., Redoblado-Hodge, M. A., Lewis, S. J., Scott, E. M., & Hickie, I. B. (2010). Cognitive training in affective disorders improves memory: A preliminary study using the NEAR approach. Journal of Affective Disorders, 121(3): 258–262.Google Scholar

Olsson, A. K., Helldin, L., Hjarthag, F., & Norlander, T. (2012). Psychometric properties of a performance-based measurement of functional capacity, the UCSD performance-based skills assessment – brief version. Psychiatry Research, 197(3): 290–294.Google Scholar

Patterson, T. L., Goldman, S., McKibbin, C. L., Hughs, T., & Jeste, D. V. (2001). UCSD performance-based skills assessment: Development of a new measure of everyday functioning for severely mentally ill adults. Schizophrenia Bulletin, 27(2): 235–245.Google Scholar

Pei, Z., Meng, R., Zhuang, Z., Zhao, Y., Liu, F., Zhu, M. Z., & Li, R. (2013). Cardiac peroxisome proliferator-activated receptor-gamma expression is modulated by oxidative stress in acutely infrasound-exposed cardiomyocytes. Cardiovascular Toxicology, 13(4): 307–315.Google Scholar

Raskin, J., Wiltse, C. G., Siegal, A., Sheikh, J., Xu, J., Dinkel, J. J., … Mohs, R. C. (2007). Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: An 8-week, double-blind, placebo-controlled trial. American Journal of Psychiatry, 164(6): 900–909.CrossRefGoogle ScholarPubMed

Rethorst, C. D., Sunderajan, P., Greer, T. L., Grannemann, B. D., Nakonezny, P. A., Carmody, T. J., & Trivedi, M. H. (2013a). Does exercise improve self-reported sleep quality in non-remitted major depressive disorder? Psychological Medicine, 43(4): 699–709.Google Scholar

Rethorst, C. D., Toups, M. S., Greer, T. L., Nakonezny, P. A., Carmody, T. J., Grannemann, B. D., … Trivedi, M. H. (2013b). Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Molecular Psychiatry, 18(10): 1119–1124.Google Scholar

Sasada, K., Iwamoto, K., Kawano, N., Kohmura, K., Yamamoto, M., Aleksic, B., … Ozaki, N. (2013). Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function in healthy volunteers. Human Psychopharmacology, 28(3): 281–286.Google Scholar

Schrijvers, D., Maas, Y. J., Pier, M. P., Madani, Y., Hulstijn, W., & Sabbe, B. G. (2009). Psychomotor changes in major depressive disorder during sertraline treatment. Neuropsychobiology, 59(1): 34–42.CrossRefGoogle ScholarPubMed

Schulze-Rauschenbach, S. C., Harms, U., Schlaepfer, T. E., Maier, W., Falkai, P., & Wagner, M. (2005). Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression. British Journal of Psychiatry, 186: 410–416.Google Scholar

Semkovska, M. & McLoughlin, D. M. (2010). Objective cognitive performance associated with electroconvulsive therapy for depression: A systematic review and meta-analysis. Biological Psychiatry, 68(6): 568–577.Google Scholar

Soczynska, J. K., Ravindran, L. N., Styra, R., McIntyre, R. S., Cyriac, A., Manierka, M. S., & Kennedy, S. H. (2014). The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: Results from a randomized controlled trial. Psychiatry Research, 220(1–2): 245–250.CrossRefGoogle ScholarPubMed

Theunissen, E. L., Street, D., Hojer, A. M., Vermeeren, A., Van Oers, A., & Ramaekers, J. G. (2013). A randomized trial on the acute and steady-state effects of a new antidepressant, vortioxetine (Lu AA21004), on actual driving and cognition. Clinical Pharmacology & Therapeutics, 93(6): 493–501.CrossRefGoogle ScholarPubMed

Thorsen, A. L., Johansson, K., & Loberg, E. M. (2014). Neurobiology of cognitive remediation therapy for schizophrenia: A systematic review. Frontiers in Psychiatry, 5: 103.Google Scholar

Trivedi, M. H., Greer, T. L., Church, T. S., Carmody, T. J., Grannemann, B. D., Galper, D. I., … Blair, S. N. (2011). Exercise as an augmentation treatment for nonremitted major depressive disorder: A randomized, parallel dose comparison. Journal of Clinical Psychiatry, 72(5): 677–684.Google Scholar

Zimmerman, M., McGlinchey, J. B., Posternak, M. A., Friedman, M., Attiullah, N., & Boerescu, D. (2006). How should remission from depression be defined? The depressed patient’s perspective. American Journal of Psychiatry, 163(1): 148–150.Google Scholar